Edition:
United States

Spark Therapeutics Inc (ONCE.OQ)

ONCE.OQ on NASDAQ Stock Exchange Global Select Market

55.55USD
21 Sep 2018
Change (% chg)

$-1.63 (-2.85%)
Prev Close
$57.18
Open
$57.86
Day's High
$57.90
Day's Low
$54.40
Volume
528,056
Avg. Vol
193,597
52-wk High
$96.51
52-wk Low
$41.06

Chart for

About

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a... (more)

Overall

Beta: 2.20
Market Cap(Mil.): $2,087.10
Shares Outstanding(Mil.): 37.57
Dividend: --
Yield (%): --

Financials

  ONCE.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -2.82 -- --
ROI: -19.07 1.50 12.72
ROE: -22.92 0.19 14.85

BRIEF-Spark Therapeutics Reports Q1 Loss Per Share Of $1.25

* SPARK THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT BUSINESS PROGRESS

May 08 2018

BRIEF-Spark Therapeutics Says Entered Into Asset Purchase Agreement With Jazz Pharmaceuticals Ireland Ltd

* SPARK THERAPEUTICS SAYS ENTERED INTO ASSET PURCHASE AGREEMENT WITH JAZZ PHARMACEUTICALS IRELAND LIMITED - SEC FILING

Apr 30 2018

Earnings vs. Estimates